Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 21, 2017
Symcel has secured a Horizon 2020 funding to support the company’s evaluation of improved combination testing of antibiotics against extensively drug-resistant bacteria in sepsis patients.
read more
Wednesday, December 21, 2016
Symcel, the provider of the cell-based assay tool for real-time cellular bioenergetic measurements, calScreener™, has partnered with Colzyx to test 25 different new collagen VI derived antimicrobial peptides – analyzing their capability to kill ...
read more
Monday, February 12, 2018
Symcel is expanding to bring its patented technology to the clinical antimicrobial susceptibility testing (AST) markets.
read more
Wednesday, March 21, 2018
Symbiotix Biotherapies has entered into a license agreement with Harvard University.
read more
Symbiosis has signed a supply agreement with AstraZeneca for sterile manufacture of the COVID-19 recombinant adenovirus vaccine known as AZD1222.
read more
Symbiosis has successfully completed a scheduled inspection by the UK Government regulator, the MHRA.
read more
Friday, September 28, 2018
Symbiosis Pharmaceutical Services has reported FDA approval for its viral vector manufacturing fill/finish process at its biologics manufacturing facility located in Scotland, UK.
read more
Symbiosis Pharmaceutical Services has secured £1million of finance from Allied Irish Bank (GB) to support its 2020 growth strategy.
read more
Symbiosis Pharmaceutical Services has appointed Joanne Anderson as chief commercial officer, strengthening the leadership team at the Stirling, UK–based contract development and manufacturing organization (CDMO).
read more
Tuesday, December 17, 2019
Contract Manufacturing Organization (CMO) Symbiosis Pharmaceutical Services has expanded its sterile biologics manufacturing facility in Scotland, UK by 25%.
read more
Tuesday, October 07, 2025
Symbiosis Pharmaceutical Services has successfully completed qualification of its new FPD 50 Flexicon automated fill/finish line at its new commercial production facility in Stirling, Scotland.
read more
Symbiosis Pharmaceutical Services has appointed Wendy Cook as a Qualified Person (QP) to further strengthen its regulatory and quality leadership team.
read more
Thursday, November 06, 2025
Symbiosis Pharmaceutical Services has strengthened its business development team in the US with the dual appointments of Kevin O’Brien and LeeAnn Nguyen as Vice Presidents of Business Development for North America, and North America and Asia ...
read more
Symbiosis Pharmaceutical Services has manufactured their first 10,000 vial batch at the company’s new facility in Stirling, UK.
read more
Monday, September 09, 2024
Symbiosis Pharmaceutical Services Ltd. announced the purchase of new premises in Stirling, Scotland, UK. The additional space will significantly increase manufacturing capacity, strengthen the current Symbiosis commercial manufacturing service ...
read more